“Labsan is renowned for its ability to work with with pharmaceutical laboratories throughout the entire life cycle of medicines"
The Álava-based company is part of the TECNALIA group and is taking part in the Made in Araba exhibition for 2026, organised by the Provincial Council of Álava
Labsan, alongside TECNALIA's pharmaceutical development division, is renowned for its ability to work with pharmaceutical laboratories and organisations throughout the entire life cycle of medicines and medical devices, from their formulation and development right through to their manufacture. It is one of the 28 entities selected to take part in the Made in Araba 2026 exhibition, an initiative promoted by the Provincial Council of Álava to introduce the talent, innovation and industrial capacity of Álava-based companies to the public.
The exhibition, which will be held in Plaza General Loma in Vitoria-Gasteiz, highlights the role played by local companies in strategic sectors, showcasing the developments, products and capabilities that contribute to Álava’s standing as a leader in industry and innovation at both a national and international level.
Labsan is a company that exemplifies the strength of the Alava bio-health ecosystem:
- It specialises in developing, scaling-up and manufacturing medical devices and solutions for the pharmaceutical, healthcare and biotechnology sectors.
- It provides its customers with full support, which speeds up the launch of new products onto the market while ensuring the highest standards of quality, safety and regulatory compliance.
A value proposition based on full support
Labsan’s value proposition is based on a combination of scientific expertise, industrial capability and regulatory experience. As a result, the company is able to undertake projects ranging from defining and optimising formulations to manufacturing pilot and industrial batches, acting as a technology partner for innovative companies looking to reduce risks and speed up their development processes.
Its operations help to strengthen Álava’s industrial and healthcare sectors, by driving the generation of knowledge, skilled employment and new business opportunities in high value-added sectors.
A strategic partnership with TECNALIA as a Contract Development and Manufacturing Organisation (CDMO)
Labsan works closely with TECNALIA’s pharmaceutical development division, forming part of a joint proposal aimed at offering advanced CDMO (Contract Development and Manufacturing Organisation) services.
This collaboration has allowed TECNALIA and Labsan to combine complementary capabilities, ranging from applied research, galenic development and product characterisation to scaling up, validation and manufacturing.
- Pharmaceutical, biotechnology and healthcare companies can access a complete value chain to turn an idea or scientific development into a product ready for industrial transfer or commercialisation.
- The combination of TECNALIA’s R&D capabilities and Labsan’s industrial expertise provides a comprehensive support model that will make it easier to speed up innovative projects and introduce them more efficiently into the market.
Innovation to benefit the region
Labsan’s involvement in Made in Araba) reflects the company’s commitment to the economic and technological development of Álava and highlights the importance of having companies capable of turning scientific knowledge into real-world solutions for industry and society.
Initiatives such as Made in Araba help to introduce this reality to the public, and show how local companies contribute on a daily basis to improving competitiveness, driving innovation and making an impact beyond our borders.
Labsan exemplifies how collaboration between industry, science and technology translates into new opportunities for the healthcare sector and greater added value for the Basque business community.